{
  "trial_id": "NCT00751114",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Duration of diabetes, Baseline HbA1c, Body Mass Index (BMI), Fasting Plasma Glucose (FPG), 7-point plasma glucose (PG) profiles, Percentage of patients with HbA1c <7% and <6.5%, Hypoglycemia occurrence, Body weight, Renal function (serum creatinine), Hepatic function (ALT, AST), History of sensitivity to study drugs, Alcohol or drug abuse history, Pregnancy status, Use of systemic corticosteroids, Participation in another clinical trial.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "Gender"
        ],
        [
          "Body Weight",
          "Body weight"
        ],
        [
          "Body Mass Index",
          "Body Mass Index (BMI)"
        ],
        [
          "Duration of diabetes",
          "Duration of diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose (FPG)"
        ]
      ],
      "remaining_reference_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-monitored Fasting Plasma Glucose",
        "Total Cholesterol",
        "High-Density Lipoprotein (HDL) Cholesterol",
        "Low-Density Lipoprotein (LDL) Cholesterol",
        "Triglycerides"
      ],
      "remaining_candidate_features": [
        "Age",
        "7-point plasma glucose (PG) profiles",
        "Percentage of patients with HbA1c <7% and <6.5%",
        "Hypoglycemia occurrence",
        "Renal function (serum creatinine)",
        "Hepatic function (ALT, AST)",
        "History of sensitivity to study drugs",
        "Alcohol or drug abuse history",
        "Pregnancy status",
        "Use of systemic corticosteroids",
        "Participation in another clinical trial"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Fasting Plasma Glucose, 7-point plasma glucose profiles, Percentage of patients with HbA1c <7% and <6.5%, Hypoglycemia occurrence, Body weight, Overall safety,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Body Weight",
          "Body weight"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "Duration of diabetes",
        "At least one diabetic late complication",
        "Self-monitored Fasting Plasma Glucose",
        "Total Cholesterol",
        "High-Density Lipoprotein (HDL) Cholesterol",
        "Low-Density Lipoprotein (LDL) Cholesterol",
        "Triglycerides"
      ],
      "remaining_candidate_features": [
        "Age",
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "7-point plasma glucose profiles",
        "Percentage of patients with HbA1c <7% and <6.5%",
        "Hypoglycemia occurrence",
        "Overall safety"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Body Mass Index, HbA1c, Fasting Plasma Glucose, Duration of Diabetes, Metformin Dose, History of Hypertension, History of Dyslipidemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-monitored Fasting Plasma Glucose",
        "Total Cholesterol",
        "High-Density Lipoprotein (HDL) Cholesterol",
        "Low-Density Lipoprotein (LDL) Cholesterol",
        "Triglycerides"
      ],
      "remaining_candidate_features": [
        "Age",
        "Male",
        "Metformin Dose",
        "History of Hypertension",
        "History of Dyslipidemia"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, BMI, duration of diabetes, HbA1c at baseline, FPG at baseline, metformin dose at baseline, history of hypertension, history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "HbA1c at baseline"
        ],
        [
          "Fasting Plasma Glucose",
          "FPG at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-monitored Fasting Plasma Glucose",
        "Total Cholesterol",
        "High-Density Lipoprotein (HDL) Cholesterol",
        "Low-Density Lipoprotein (LDL) Cholesterol",
        "Triglycerides"
      ],
      "remaining_candidate_features": [
        "Age",
        "race",
        "ethnicity",
        "metformin dose at baseline",
        "history of hypertension",
        "history of cardiovascular disease",
        "smoking status"
      ]
    }
  }
}